US 10875893
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
granted A61KA61K38/00A61K38/005
Quick answer
US patent 10875893 (Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods) held by Apellis Pharmaceuticals, Inc. expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Apellis Pharmaceuticals, Inc.
- Grant date
- Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K38/00, A61K38/005, A61K38/10, A61K47/542